ChromoCure to begin clinical testing of ChromoSomal Scanning Technology for cervical cancer soon
ChromoCure, Inc will be starting clinical testing and trials for its landmark ChromoSomal Scanning Technology as applied to cervical cancer soon. These clinical testing and trials are anticipated to be the first in a series relating to the different forms of cancer.

Read more on PharmaBiz